Desert Ridge Front Desk Our beautiful, MA at our Desert Ridge location
Clinical studies have shown that individuals using semaglutide experience substantial weight loss, often exceeding that achieved with other medications
The STEP-HFpEF trial randomised 529 patients with obesity (BMI 30 kg/m 2 ), HFpEF (left ventricular ejection fraction [LVEF] 45%) and New York Heart Association (NYHA) Class II symptoms to once-weekly subcutaneous semaglutide 2.4 mg or placebo
Most people resort to ad hoc notes and guesswork because it feels doable
Common side effectsnausea, vomiting, constipation, and injection site reactionsoccur at similar rates across both formulations
If you are ready to start a program that prioritizes your individual needs with medical supervision and transparent care, your next step is simple